Morphological evidence that xenon neuroprotects against N-methyl-DL-aspartic acid-induced damage in the rat arcuate nucleus: A time-dependent study

Annals of the New York Academy of Sciences

Volumn 1074, Issue , 2006, Pages 650-658

  Natale, Gianfranco ^a   Cattano, Davide ^a   Abramo, Antonio ^a   Forfori, Francesco ^a   Fulceri, Federica ^a   Fornai, Francesco ^a   Paparelli, Antonio ^a   Giunta, Francesco ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Arcuate nucleus; N methyl DL aspartic acid; Neuroprotection; NMDA receptor; Xenon

Indexed keywords

ANESTHETIC AGENT; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYLASPARTIC ACID; NITROGEN ACID DERIVATIVE; OXYGEN; XENON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCUATE NUCLEUS; BRAIN SLICE; CAGE; CALCIUM TRANSPORT; CELL NUCLEUS; CELL POPULATION; CELL SURVIVAL; CELL ULTRASTRUCTURE; CHROMATIN; CONFERENCE PAPER; CONTROLLED STUDY; CYTOARCHITECTURE; CYTOPLASM; DISEASE MODEL; DRUG EFFECT; FEMALE; MICROSCOPY; MITOCHONDRION; NERVE CELL DEGENERATION; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; RAT; RAT STRAIN; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALIA;

EID: 33749559195     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1369.063     Document Type: Conference Paper

References (31)

1. BRACKEN, A. et al. 1956. A trial of xenon as a non-explosive anesthetic. Anaesthesia 11: 40-49.
2. BAUMERT, J.H. et al. 2005. Hemodynamic effects of hemorrhage during xenon anesthesia in pigs. Br. J. Anaesth. 94: 727-732.
3. GIUNTA, F. et al. 1996. Xenon: a review of its anesthetic and pharmacological properties. Appl. Cardiopulm. Pathophysiol. 6: 95-103.
4. BEDI, A. et al. 2002. The effects of subanesthetic concentrations of xenon in volunteers. Anaesthesia 57: 233-241.
5. LUTTROPP, H.H. et al. 1994. Clinical experience with minimal flow xenon anesthesia. Acta Anaesthesiol. Scand. 38: 121-125.
6. YAGI, M. et al. 1995. Analgesic and hypnotic effects of subanesthetic concentrations of xenon in human volunteers: comparison with nitrous oxide. Br. J. Anaesth. 74: 670-673.
7. BAUMERT, J.H. et al. 2005. Xenon anesthesia may preserve cardiovascular function in patients with heart failure. Acta Anaesthesiol. Scand. 49: 743-749.
8. SANDERS, R.D. et al. 2005. Xenon: elemental anesthesia in clinical practice. Br. Med. Bull. 22: 115-135.
9. NATALE, G. et al. 1998. Main organ morphology and blood analysis after subchronic exposure to xenon in rats. Appl. Cardiopulm. Pathophysiol. 7: 227-233.
10. NATALE, G. et al. 2002. Effects of repeated exposures to xenon on rat adrenal cortex ultrastructure. J. Submicrosc. Cytol. Pathol. 34: 329-334.
11. FRANKS, N.P. et al. 1998. How does xenon produce anesthesia? Nature 396: 324.
12. DE SOUSA, S.L. et al. 2000. Contrasting synaptic actions of the inhalational general anesthetics isoflurane and xenon. Anesthesiology 92: 1055-1066.
13. OLNEY, J.W. 1969. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164: 719-721.
14. HARADA, H. et al. 1999. Isoflurane reduces N-methyl-D-aspartate toxicity in vivo in the rat cerebral cortex. Anesth. Analg. 89: 1442-1447.
15. KUDO, M. et al. 2001. Effects of volatile anesthetics on N-methyl-D-aspartate excitotoxicity in primary rat neuronal-glial cultures. Anesthesiology 95: 756-765.
16. ARROWSMITH, J.E. et al. 1998. Neuroprotection of the brain during cardiopulmonary bypass: a randomized trial of remacemide during coronary artery bypass in 171 patients. Stroke 29: 2357-2362.
17. 2O enhances ketamine-induced c-Fos expression in the rat posterior cingulate and retrosplenial cortices. Anesth. Analg. 92: 362-368.
18. WILHELM, S. et al. 2002. Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology 96: 1485-1491.
19. HOLZWARTH-MCBRIDE, M.A. et al. 1976. Monosodium glutamate induced lesions of the arcuate nucleus. I. Endocrine deficiency and ultrastructure of the median eminence. Anat. Rec. 186: 185-196.
20. HOLZWARTH-MCBRIDE, M. A. et al. 1976. Monosodium glutamate induced lesions of the arcuate nucleus. II. Fluorescence histochemistry of catecholamines. Anat. Rec. 186: 197-206.
21. XUE, Y.-D. et al. 1997. Nitric oxide synthase-, N-methyl-D-aspartate receptor-, glutamate- and aspartate-immunoreactive neurons in the mouse arcuate nucleus: effects of neonatal treatment with monosodium glutamate. Acta Neuropathol. 94: 572-582.
22. HU, L. et al. 1998. Exogenous glutamate enhances glutamate receptor subunit expression during selective neuronal injury in the ventral arcuate nucleus of postnatal mice. Neuroendocrinology 68: 77-88.
23. GOLDSMITH, P.C. 2000. Neuroglial responses to elevated glutamate in the medial basal hypothalamus of the infant mouse. J. Nutr. 130: 1032S-1038S.
24. NAKANISHI, N. 1992. Molecular diversity of glutamate receptors and implications for brain functions. Science 258: 597-603.
25. BRANN, D.W. 1995. Glutamate: a major excitatory transmitter in neuroendocrine regulation. Neuroendocrinology 61: 213-225.
26. ETCHEVERRY, G.J. & A.P. DE IRALDI. 1968. Infrastructure of neurons in the arcuate nucleus of the rat. Anat. Rec. 160: 239-254.
27. MARTIN, L.J. et al. 1998. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis. Brain Res. Bull. 46: 281-309.
28. SATTLER, R. & M. TYMIANSKI. 2001. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol. Neurobiol. 24: 107-129.
29. EYIGOR, O. et al. 2001. Distribution of ionotropic glutamate receptor subunit mRNAs in the rat hypothalamus. J. Comp. Neurol. 434: 101-124.
30. MA, D. et al. 2002. Neuroprotective and neurotoxic properties of the "inert" gas, xenon. Br. J. Anaesth. 89: 739-746.
31. ABRAINI, J.H. et al. 2005. Potentially neuroprotective and therapeutic properties of nitrous oxide and xenon. Ann. N. Y. Acad. Sci. 1053: 289-300.